Table 2. Results at IFAT (the highest dilution titre is reported), cytological examination and PCR results for skin, bone marrow and conjunctival swabs of positive dogs at follow-up time points and the final test period.
| Dogs | September 2011 | November 2011 | March 2012 | |||||
| Serology | Serology | PCR | Cytology | Serology | PCR | |||
| Skin | Skin | Bone marrow | Conjunctival swabs | |||||
| Dog1 | − | − | − | − | − | + | − | − |
| Dog 2* | − | − | − | + | 1∶320 | + | + | − |
| Dog 3 | − | − | − | − | − | + | − | − |
| Dog 4 | − | − | − | − | 1∶160 | + | + | − |
| Dog 5 | − | 1∶80 | + | − | 1∶160 | − | − | − |
| Dog 6 | − | − | − | + | 1∶320 | + | + | − |
| Dog 7 | − | 1∶80 | − | + | 1∶80 | − | − | − |
| Dog 8* | − | 1∶80 | + | + | 1∶160 | − | − | + |
| Dog 9 | − | − | − | − | 1∶160 | + | − | − |
| Dog 10 | − | − | − | − | 1∶320 | − | + | − |
| Dog 11 | − | 1∶80 | + | − | 1∶640 | − | + | + |
| Dog 12 | − | 1∶80 | + | − | 1∶80 | − | − | − |
| Dog 13 | − | 1∶80 | − | − | − | − | − | − |
| Dog 14 | − | 1∶80 | + | |||||
| Dog 15 | − | − | − | − | 1∶160 | + | + | + |
| Dog 16 | − | − | − | − | − | + | − | + |
| Dog 17* | − | 1∶80 | + | + | 1∶1240 | + | + | + |
| Dog 18* | − | 1∶80 | + | − | 1∶160 | + | + | + |
| Dog 19* | − | + | − | − | 1∶320 | − | + | + |
| Dog 20 | + | − | − | − | − | − | − | − |
| Dog 21 | − | − | − | − | 1∶80 | + | − | − |
Animals displaying clinicopathological alterations suggestive for Leishmania infantum infection are marked with an asterisk.